CRM
60
-7
DLTR
38
-4
KLAC
38
-6
ADSK
66
-4
ALL
50
2
ABT
59
2
INTU
58
-3
RCL
83
-2
HAS
30
-2
PG
50
2
CAT
59
-2
JBHT
56
-3
VNO
46
-13
CPB
22
-5
MSFT
48
-9
ADP
65
-3
AMGN
42
-4
NOC
41
9
NI
72
4
MS
77
-2
CRM
60
-7
DLTR
38
-4
KLAC
38
-6
ADSK
66
-4
ALL
50
2
ABT
59
2
INTU
58
-3
RCL
83
-2
HAS
30
-2
PG
50
2
CAT
59
-2
JBHT
56
-3
VNO
46
-13
CPB
22
-5
MSFT
48
-9
ADP
65
-3
AMGN
42
-4
NOC
41
9
NI
72
4
MS
77
-2
Financhill
Back

DB Gold Double Long ETN Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
43

DGP
DB Gold Double Long ETN

Last Price:
62.80
Seasonality Move:
8.11%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
43
DB Gold Double Long ETN (DGP) is a Sell

Is DB Gold Double Long ETN a Buy, Sell or Hold?

  • The current DB Gold Double Long ETN [DGP] share price is $62.41. The Score for DGP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • DGP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DGP Stock Price Chart

What is DB Gold Double Long ETN's stock price today?

  • The DB Gold Double Long ETN share price today is $62.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DGP is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

DGP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.28 Sell
Relative Strength Index (14 RSI): 31.66 Sell
Chaikin Money Flow: -8445 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.37 - 73.09) Sell
Bollinger Bands (100): (57.47 - 68.81) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

DGP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.97 Sell
20-day SMA: 69.84 Sell
50-day SMA: 67.94 Sell
200-day SMA: 56.92 Buy
8-day EMA: 65.6 Sell
20-day EMA: 67.92 Sell
50-day EMA: 67.14 Sell
200-day EMA: 58.38 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

DB Gold Double Long ETN Earnings Growth & DGP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

DB Gold Double Long ETN Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):